Plasmodium falciparum adhesion in the placenta

Area of Science:

• Immunology
• Parasitology
• Obstetrics

Background:

• Placental malaria, caused by Plasmodium falciparum sequestration, leads to severe maternal and fetal complications.
• P. falciparum placental isolates consistently adhere to chondroitin sulfate A (CSA) on the syncytiotrophoblast.
• Variant surface antigen PfEMP1 forms binding CSA (PfEMP1(varCSA)) are conserved in field isolates.

Purpose of the Study:

• To investigate the molecular mechanisms of P. falciparum sequestration in the placenta.
• To identify conserved parasite surface proteins involved in placental malaria.
• To explore potential vaccine targets for preventing pregnancy malaria.

Main Methods:

• Analysis of placental P. falciparum isolates for CSA binding.
• Characterization of PfEMP1 variant surface antigen expression in placental isolates.
• Investigation of parasite binding mechanisms in young ring-stage parasites.

Main Results:

• Placental P. falciparum isolates uniformly bind to CSA.
• PfEMP1(varCSA) forms are conserved but not upregulated upon CSA selection.
• Non-PfEMP1-mediated endothelial binding observed in early parasite stages.
• Parasite surface proteins are targets of protective antibodies.

Conclusions:

• Chondroitin sulfate A is a key adhesion molecule for P. falciparum in the placenta.
• PfEMP1(varCSA) plays a role, but other mechanisms and PfEMP1 forms may also be involved in placental sequestration.
• Vaccine development targeting placental parasite surface proteins offers a promising strategy to prevent pregnancy malaria.